Arbutus Biopharma Corporation ABUS Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
Based on trailing twelve months.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's operating margin?
- Arbutus Biopharma Corporation (ABUS) reported operating margin of 81.7% in Q1 2026.
- How has Arbutus Biopharma Corporation's operating margin changed year-over-year?
- Arbutus Biopharma Corporation's operating margin increased by 106.3% year-over-year, from -1,290.9% to 81.7%.
- What is the long-term trend for Arbutus Biopharma Corporation's operating margin?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's operating margin has grown at a -20.2% compound annual growth rate (CAGR), from -836.1% to -271%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.